Researchers believe diffusion-weighted MRI (DWI) has potential as a “rapid supplemental screening tool,” according to a study published in the American Journal of Roentgenology. Their findings show that DWI can help radiologists see mammographically occult cancers in at-risk women with dense breasts.

Lantheus Holdings, the parent company of global imaging manufacturer Lantheus Medical Imaging, has announced the first commercial shipment of Xenon Xe 133 Gas (Xenon 133), an imaging agent used when imaging the lungs, using unprocessed radiochemical Xenon 133 from Belgium’s Institute for Radioelements (IRE).

According to an announcement from Quebec’s government, beginning this November, ultrasounds performed in private radiology clinics will be covered by the provincial public health insurance agency.

Since being diagnosed with breast cancer in 2006, Sheryl Crow has also played an active role in promoting women’s health, and Hologic announced in June that she was serving as a national spokesperson for the company’s Genius 3D MAMMOGRAPHY exam. Crow took time out of her busy schedule to answer a few questions for Radiology Business. 

MEDIAN Technologies has announced it is expanding its relationship with START, a Phase 1 medical oncology company, to provide its services to more START locations. 

If a patient finds a palpable breast lump within one year of a negative mammogram, what is the best plan of action? According to a study published by the American Journal of Roentgenology, such incidents should be evaluated with targeted ultrasound instead of a second mammogram. 

Thanks to improved image quality from more affordable units, point-of-care ultrasound is on the rise. However, according to a recent survey published in Academic Radiology, a majority of radiologists are not offered a point-of-care ultrasound elective in medical school. 

Mayo Clinic and General Electric are releasing a new MRI scanner next week that specializes in brain scans and improves the patient experience.